biostudies-literatureUnknown38(4)Rojas-Carabali W<h4>Objectives</h4>To describe the clinical features of patients diagnosed with uveitic glaucoma (UG) and ocular hypertension secondary to uveitis (OHT-SU).<h4>Methods</h4>A multicentric cross-sectional study using medical records of patients with uveitis between 2013 and 2021. Uveitis and glaucoma specialists examined all patients. Variables were analyzed using the chi-square or Fisher's exact test for categorical variables. Additionally, t test, Mann-Whitney, and Kruskal-Wallis variance analysis were used for continuous variables. Finally, a Kaplan-Meier survival analysis for UG and OHT-SU development over time was done.<h4>Results</h4>Of the 660 clinical records reviewed of patients with uveitis, 191 (28.9%) had OHT-SU in at least one visit, and 108 (16.4%) of them developed UG. In all Eye (London, England)714-722https://www.ebi.ac.uk/biostudies/studies/S-EPMC10920824biostudies-literaturePrevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogota, Colombia.PMC10920824Cifuentes-Gonzalez CDelgado MFde-la-Torre AChacon-Zambrano DCruz-Reyes DLGomez-Goyeneche HFRojas-Carabali WSaad-Brahim KMejia-Salgado GfalsePrevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogota, Colombia.<h4>Objectives</h4>To describe the clinical features of patients diagnosed with uveitic glaucoma (UG) and ocular hypertension secondary to uveitis (OHT-SU).<h4>Methods</h4>A multicentric cross-sectional study using medical records of patients with uveitis between 2013 and 2021. Uveitis and glaucoma specialists examined all patients. Variables were analyzed using the chi-square or Fisher's exact test for categorical variables. Additionally, t test, Mann-Whitney, and Kruskal-Wallis variance analysis were used for continuous variables. Finally, a Kaplan-Meier survival analysis for UG and OHT-SU development over time was done.<h4>Results</h4>Of the 660 clinical records reviewed of patients with uveitis, 191 (28.9%) had OHT-SU in at least one visit, and 108 (16.4%) of them developed UG. In all 2024-01-01T00:00:00Z2024 Mar2026-07-15T00:39:55.098Z2026-06-27T03:05:42.971ZS-EPMC109208243778911010.1038/s41433-023-02757-9